PDS Biotechnology last closed at $1.04 (-12.92%) on 2026-10-06. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -1.7×. Its overall grade ranks 41 of 740 stocks in Healthcare.
About this company
PDS Biotechnology last closed at $1.04 (-12.92%) on 2026-10-06. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 41/740
Valuation grade A+
Related stocks
- MerckCompetitor
PDS Biotech의 면역항암제/백신 개발과 같은 체크포인트·면역치료 영역에서 경쟁
- Bristol Myers SquibbCompetitor
면역항암제 파이프라인 및 병용요법 개발에서 직접 경쟁
- Boehringer IngelheimCustomer
PDS Biotech의 VERSAMUNE/VERSA 플랫폼 공동개발·라이선스 협력 이력
About PDS Biotechnology
- What technical signals does PDS Biotechnology (PDSB) have?
- PDS Biotechnology current technical signals: MACD bullish cross.
- Is PDS Biotechnology a cup-and-handle pattern?
- No. PDS Biotechnology has no valid Cup signal right now.
- What published figures are available for PDS Biotechnology?
- Market cap: $54.47M. Trailing 12 months PER: -1.7×. Latest quarter PBR: -16.25×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about PDS Biotechnology, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.